Deletion of the 3q26 region including the EVI1 and MDS1 genes in a neonate with congenital thrombocytopenia and subsequent aplastic anaemia.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 22972950.
- Also identified by DOI 10.1136/jmedgenet-2012-100990.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Gene-targeting studies in mice have revealed a key role for EVI1 protein in the maintenance of haematopoiesis, and argue in favour of a gene dosage requirement for EVI1 in the regulation of haematopoietic stem cells. Furthermore, a fusion transcript of MDS1 and EVI1 has been shown to play a critical role in maintaining long-term haematopoietic stem cell function. Inappropriate activation of EVI1, usually due to a translocation, is a well known and unfavourable change in several myeloid malignancies. It is not known whether haploinsufficiency of any of these genes leads to disease in humans. SNP array analysis in a patient with in a neonate with congenital thrombocytopenia and subsequent aplastic anaemia We report for the first time a constitutional deletion encompassing the EVI1 and MDS1 genes in a human, and argue that the deletion causes congenital bone marrow failure in this patient.
Medical subject headings
- Anemia, Aplastic
- Chromosomes, Human, Pair 3
- DNA-Binding Proteins
- Proto-Oncogenes
- Sequence Deletion
- Thrombocytopenia
- Transcription Factors